SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Anthera Pharmaceuticals, Inc. Announces Additional Data from the Phase 2b PEARL-SC Presented at the American College of Rheumatology/ARHP 2012 Annual Scientific Meeting